267 related articles for article (PubMed ID: 33527648)
1. Associations between plasma neurofilament light, in vivo brain pathology, and cognition in non-demented individuals with autosomal-dominant Alzheimer's disease.
Guzmán-Vélez E; Zetterberg H; Fox-Fuller JT; Vila-Castelar C; Sanchez JS; Baena A; Garcia-Ospina G; Aguillon D; Pardilla-Delgado E; Gatchel JR; Sperling RA; Johnson K; Reiman EM; Blennow K; Lopera F; Quiroz YT
Alzheimers Dement; 2021 May; 17(5):813-821. PubMed ID: 33527648
[TBL] [Abstract][Full Text] [Related]
2. Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional and longitudinal cohort study.
Quiroz YT; Zetterberg H; Reiman EM; Chen Y; Su Y; Fox-Fuller JT; Garcia G; Villegas A; Sepulveda-Falla D; Villada M; Arboleda-Velasquez JF; Guzmán-Vélez E; Vila-Castelar C; Gordon BA; Schultz SA; Protas HD; Ghisays V; Giraldo M; Tirado V; Baena A; Munoz C; Rios-Romenets S; Tariot PN; Blennow K; Lopera F
Lancet Neurol; 2020 Jun; 19(6):513-521. PubMed ID: 32470423
[TBL] [Abstract][Full Text] [Related]
3. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.
Quiroz YT; Sperling RA; Norton DJ; Baena A; Arboleda-Velasquez JF; Cosio D; Schultz A; Lapoint M; Guzman-Velez E; Miller JB; Kim LA; Chen K; Tariot PN; Lopera F; Reiman EM; Johnson KA
JAMA Neurol; 2018 May; 75(5):548-556. PubMed ID: 29435558
[TBL] [Abstract][Full Text] [Related]
4. Plasma p-tau217 predicts in vivo brain pathology and cognition in autosomal dominant Alzheimer's disease.
Aguillon D; Langella S; Chen Y; Sanchez JS; Su Y; Vila-Castelar C; Vasquez D; Zetterberg H; Hansson O; Dage JL; Janelidze S; Chen K; Fox-Fuller JT; Aduen P; Martinez JE; Garcia G; Baena A; Guzman C; Johnson KA; Sperling RA; Blennow K; Reiman EM; Lopera F; Quiroz YT
Alzheimers Dement; 2023 Jun; 19(6):2585-2594. PubMed ID: 36571821
[TBL] [Abstract][Full Text] [Related]
5. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K;
Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117
[TBL] [Abstract][Full Text] [Related]
6. Sex differences in blood biomarkers and cognitive performance in individuals with autosomal dominant Alzheimer's disease.
Vila-Castelar C; Chen Y; Langella S; Lopera F; Zetterberg H; Hansson O; Dage JL; Janelidzde S; Su Y; Chen K; Pluim McDowell C; Martinez JE; Ramirez-Gomez L; Garcia G; Aguillon D; Baena A; Giraldo-Chica M; Protas HD; Ghisays V; Rios-Romenets S; Tariot PN; Blennow K; Reiman EM; Quiroz YT
Alzheimers Dement; 2023 Sep; 19(9):4127-4138. PubMed ID: 37279390
[TBL] [Abstract][Full Text] [Related]
7. Neuroticism Is Associated with Tau Pathology in Cognitively Unimpaired Individuals with Autosomal Dominant Alzheimer's Disease.
Baena A; Bocanegra Y; Torres V; Vila-Castelar C; Guzmán-Vélez E; Fox-Fuller JT; Gatchel JR; Sánchez J; Pluim CF; Ramirez-Gómez L; Martínez J; Pineda D; Lopera F; Quiroz YT
J Alzheimers Dis; 2021; 82(4):1809-1822. PubMed ID: 34219716
[TBL] [Abstract][Full Text] [Related]
8. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
[TBL] [Abstract][Full Text] [Related]
9. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study.
de Wolf F; Ghanbari M; Licher S; McRae-McKee K; Gras L; Weverling GJ; Wermeling P; Sedaghat S; Ikram MK; Waziry R; Koudstaal W; Klap J; Kostense S; Hofman A; Anderson R; Goudsmit J; Ikram MA
Brain; 2020 Apr; 143(4):1220-1232. PubMed ID: 32206776
[TBL] [Abstract][Full Text] [Related]
10. Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study.
Reiman EM; Quiroz YT; Fleisher AS; Chen K; Velez-Pardo C; Jimenez-Del-Rio M; Fagan AM; Shah AR; Alvarez S; Arbelaez A; Giraldo M; Acosta-Baena N; Sperling RA; Dickerson B; Stern CE; Tirado V; Munoz C; Reiman RA; Huentelman MJ; Alexander GE; Langbaum JB; Kosik KS; Tariot PN; Lopera F
Lancet Neurol; 2012 Dec; 11(12):1048-56. PubMed ID: 23137948
[TBL] [Abstract][Full Text] [Related]
11. Associations of longitudinal plasma p-tau181 and NfL with tau-PET, Aβ-PET and cognition.
Rauchmann BS; Schneider-Axmann T; Perneczky R;
J Neurol Neurosurg Psychiatry; 2021 Dec; 92(12):1289-1295. PubMed ID: 34187867
[TBL] [Abstract][Full Text] [Related]
12. Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers.
Gordon BA; Blazey TM; Christensen J; Dincer A; Flores S; Keefe S; Chen C; Su Y; McDade EM; Wang G; Li Y; Hassenstab J; Aschenbrenner A; Hornbeck R; Jack CR; Ances BM; Berman SB; Brosch JR; Galasko D; Gauthier S; Lah JJ; Masellis M; van Dyck CH; Mintun MA; Klein G; Ristic S; Cairns NJ; Marcus DS; Xiong C; Holtzman DM; Raichle ME; Morris JC; Bateman RJ; Benzinger TLS
Brain; 2019 Apr; 142(4):1063-1076. PubMed ID: 30753379
[TBL] [Abstract][Full Text] [Related]
13. Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders.
Palmqvist S; Janelidze S; Quiroz YT; Zetterberg H; Lopera F; Stomrud E; Su Y; Chen Y; Serrano GE; Leuzy A; Mattsson-Carlgren N; Strandberg O; Smith R; Villegas A; Sepulveda-Falla D; Chai X; Proctor NK; Beach TG; Blennow K; Dage JL; Reiman EM; Hansson O
JAMA; 2020 Aug; 324(8):772-781. PubMed ID: 32722745
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease.
Moscoso A; Grothe MJ; Ashton NJ; Karikari TK; Lantero Rodríguez J; Snellman A; Suárez-Calvet M; Blennow K; Zetterberg H; Schöll M;
JAMA Neurol; 2021 Apr; 78(4):396-406. PubMed ID: 33427873
[TBL] [Abstract][Full Text] [Related]
15. Association Between Visual Memory and
Bocanegra Y; Fox-Fuller JT; Baena A; Guzmán-Vélez E; Vila-Castelar C; Martínez J; Torrico-Teave H; Lopera F; Quiroz YT
J Int Neuropsychol Soc; 2021 Jan; 27(1):47-55. PubMed ID: 32762790
[TBL] [Abstract][Full Text] [Related]
16. Blood biomarkers of neurodegeneration associate differently with amyloid deposition, medial temporal atrophy, and cerebrovascular changes in APOE ε4-enriched cognitively unimpaired elderly.
Koivumäki M; Ekblad L; Lantero-Rodriguez J; Ashton NJ; Karikari TK; Helin S; Parkkola R; Lötjönen J; Zetterberg H; Blennow K; Rinne JO; Snellman A
Alzheimers Res Ther; 2024 May; 16(1):112. PubMed ID: 38762725
[TBL] [Abstract][Full Text] [Related]
17. Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.
Fortea J; Carmona-Iragui M; Benejam B; Fernández S; Videla L; Barroeta I; Alcolea D; Pegueroles J; Muñoz L; Belbin O; de Leon MJ; Maceski AM; Hirtz C; Clarimón J; Videla S; Delaby C; Lehmann S; Blesa R; Lleó A
Lancet Neurol; 2018 Oct; 17(10):860-869. PubMed ID: 30172624
[TBL] [Abstract][Full Text] [Related]
18. Plasma Tau and Neurofilament Light in Frontotemporal Lobar Degeneration and Alzheimer Disease.
Illán-Gala I; Lleo A; Karydas A; Staffaroni AM; Zetterberg H; Sivasankaran R; Grinberg LT; Spina S; Kramer JH; Ramos EM; Coppola G; La Joie R; Rabinovici GD; Perry DC; Gorno-Tempini ML; Seeley WW; Miller BL; Rosen HJ; Blennow K; Boxer AL; Rojas JC
Neurology; 2021 Feb; 96(5):e671-e683. PubMed ID: 33199433
[TBL] [Abstract][Full Text] [Related]
19. Olfactory Function and Markers of Brain Pathology in Non-Demented Individuals with Autosomal Dominant Alzheimer's Disease.
Ramirez-Gomez L; Albers MW; Baena A; Vila-Castelar C; Fox-Fuller JT; Sanchez J; Jain F; Albers AD; Lopera F; Quiroz YT
J Alzheimers Dis; 2022; 88(2):721-729. PubMed ID: 35694921
[TBL] [Abstract][Full Text] [Related]
20. Plasma NfL is associated with the APOE ε4 allele, brain imaging measurements of neurodegeneration, and lower recall memory scores in cognitively unimpaired late-middle-aged and older adults.
Malek-Ahmadi M; Su Y; Ghisays V; Luo J; Devadas V; Chen Y; Lee W; Protas H; Chen K; Zetterberg H; Blennow K; Caselli RJ; Reiman EM
Alzheimers Res Ther; 2023 Apr; 15(1):74. PubMed ID: 37038190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]